AbbVie shares tumble after schizophrenia drug disappoints – Financial Times

AbbVie shares tumble after schizophrenia drug disappoints  Financial Times AbbVie tumbles on drug test disappointment, Bristol-Myers gains  Yahoo Finance Bristol Soars 11% As Investors Question AbbVie’s Costly ‘Mistake’  Investor’s Business Daily Crown jewel … Read More